These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ring-fused thiadiazines as core structures for the development of potent AMPA receptor potentiators. Pirotte B; Francotte P; Goffin E; Fraikin P; Danober L; Lesur B; Botez I; Caignard DH; Lestage P; de Tullio P Curr Med Chem; 2010; 17(30):3575-82. PubMed ID: 20738245 [TBL] [Abstract][Full Text] [Related]
3. [Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances]. Raevskiĭ KS; Eremin KO Biomed Khim; 2004; 50(6):523-38. PubMed ID: 15707268 [TBL] [Abstract][Full Text] [Related]
4. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures. Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496 [TBL] [Abstract][Full Text] [Related]
5. AMPA receptor-positive allosteric modulators for the treatment of schizophrenia: an overview of recent patent applications. Ward SE; Pennicott LE; Beswick P Future Med Chem; 2015; 7(4):473-91. PubMed ID: 25875874 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in positive allosteric modulators of the AMPA receptor. Morrow JA; Maclean JK; Jamieson C Curr Opin Drug Discov Devel; 2006 Sep; 9(5):571-9. PubMed ID: 17002217 [TBL] [Abstract][Full Text] [Related]
8. AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders. Reuillon T; Ward SE; Beswick P Curr Top Med Chem; 2016; 16(29):3536-3565. PubMed ID: 27363568 [TBL] [Abstract][Full Text] [Related]
9. AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook. Chang PK; Verbich D; McKinney RA Eur J Neurosci; 2012 Jun; 35(12):1908-16. PubMed ID: 22708602 [TBL] [Abstract][Full Text] [Related]
11. In search of novel AMPA potentiators. Francotte P; de Tullio P; Fraikin P; Counerotte S; Goffin E; Pirotte B Recent Pat CNS Drug Discov; 2006 Nov; 1(3):239-46. PubMed ID: 18221205 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862 [TBL] [Abstract][Full Text] [Related]
13. 5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds. Ivachtchenko AV; Ivanenkov YA; Skorenko AV Expert Opin Ther Pat; 2012 Oct; 22(10):1123-68. PubMed ID: 22957857 [TBL] [Abstract][Full Text] [Related]
14. AMPA Receptors as Therapeutic Targets for Neurological Disorders. Lee K; Goodman L; Fourie C; Schenk S; Leitch B; Montgomery JM Adv Protein Chem Struct Biol; 2016; 103():203-61. PubMed ID: 26920691 [TBL] [Abstract][Full Text] [Related]
15. Structure based evolution of a novel series of positive modulators of the AMPA receptor. Jamieson C; Maclean JK; Brown CI; Campbell RA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Moir EM; Morrow JA; Pantling J; Rankovic Z; Smith L Bioorg Med Chem Lett; 2011 Jan; 21(2):805-11. PubMed ID: 21190850 [TBL] [Abstract][Full Text] [Related]